W.O.M. World of Medicine AG

EANS-News: W.O.M. World of Medicine AG
Sales and earnings in Q1/09 above plan for 2009

WORLD OF MEDICINE boosts its innovative power

@@start.t1@@--------------------------------------------------------------------------------   Corporate news transmitted by euro adhoc. The issuer/originator is solely   responsible for the content of this announcement. --------------------------------------------------------------------------------@@end@@

balance/3-Month Report 2009

Berlin (euro adhoc) - In the first three months of 2009, sales and earnings of medical device manufacturer WORLD OF MEDICINE were slightly above planning for the year 2009 as a whole. The volume of sales reached TEUR9,810 (same period last year: TEUR10,791), and outpaced last year's quarterly average (TEUR9,241) by 6.2%. Major orders placed after product launches strongly influenced the figures reported for the first quarter of 2008. This rapid pace must be viewed relative to the business performance over the remainder of 2008.The return on sales before taxes in the first thee months of 2009 equaled 11.3%, and was slightly above the figure planned for business year 2009 (11%).

"We are taking a realistic and optimistic approach to the future," says Peter P. Wiest, CEO of WORLD OF MEDICINE. "Our earnings in the first quarter of 2009 speak for themselves. However, in these times of weaker markets, we are focusing efforts into boosting our innovative power. Our priority is not to achieve goals on short-term yields, but instead to safeguard the market position of our Company, and to secure our employees' jobs over the medium- and long term. For this reason, we are intentionally stepping up our investments in strategically important R&D projects. We are currently reviewing the effects on our 2009 earnings goal."

The consequences of the downward economic cycle on WORLD OF MEDICINE's business are difficult to assess with absolute certainty. WORLD OF MEDICINE is expecting a restraint development in the 2nd quarter, followed by a recovery at year-end 2009. At this time, the Company is reassigning employees from departments which lag in orders to production lines that are being used to full capacity. Despite this, the Management Board may enforce a short-time work schedule on a temporary basis (starting in May) as a tool for the affected divisions.

The entire Quarterly Financial Report for the first 3 months of 2009 is available at: www.world-of-medicine.com/wsc/pdf/wom/en/qr_3monthreport_2009_wom.pdf

WORLD OF MEDICINE and its technologies are paving the way in Minimally Invasive Surgery - or MIS for short. This approach includes safe and gentle surgical procedures conducted not through major incisions, but through keyhole or puncture incisions. The Company is the global market leader in a niche of this future market.

@@start.t2@@end of announcement                                                 euro adhoc

ots Originaltext: W.O.M. World of Medicine AG
Im Internet recherchierbar: http://www.presseportal.ch

Further inquiry note:
Stefanie Gehrke
Tel.: +49 (0)30 399 81 566
E-Mail: stefanie.gehrke@womcorp.com

Branche: Pharmaceuticals
ISIN:      DE0006637390
WKN:        663739
Index:    CDAX, Prime All Share, Technologie All Share
Börsen:  Börse Frankfurt / regulated dealing/prime standard
              Börse Berlin / free trade
              Börse Hamburg / free trade
              Börse Stuttgart / free trade
              Börse Düsseldorf / free trade
              Börse München / free trade

Weitere Meldungen: W.O.M. World of Medicine AG

Das könnte Sie auch interessieren: